12-Week Efficacy And Safety Of Sotagliflozin, A Dual Sglt1 And Sglt2 Inhibitor, As Adjunct Therapy To Insulin In Young Adults With Poorly Controlled Type 1 Diabetes (Jdrf Study)Bruce W. Bode,Phillip Banks, Sangeeta Sawhney,Paul StrumphDIABETES（2017）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
